Yuki N - Search Results

1

IgG anti-GQ1b positive acute ataxia without ophthalmoplegia.

Mori M, Kuwabara S, Koga M, Asahina M, Ogawara K, Hattori T, Yuki N. Mori M, et al. Among authors: yuki n. J Neurol Neurosurg Psychiatry. 1999 Nov;67(5):668-70. doi: 10.1136/jnnp.67.5.668. J Neurol Neurosurg Psychiatry. 1999. PMID: 10519878 Free PMC article.

2

Acute isolated bulbar palsy with anti-GT1a IgG antibody subsequent to Campylobacter jejuni enteritis.

Onodera M, Mori M, Koga M, Kamitsukasa I, Fukutake T, Hattori T, Yuki N, Kuwabara S. Onodera M, et al. Among authors: yuki n. J Neurol Sci. 2002 Dec 15;205(1):83-4. doi: 10.1016/s0022-510x(02)00241-1. J Neurol Sci. 2002. PMID: 12409189

3

Fisher syndrome or Bickerstaff brainstem encephalitis? Anti-GQ1b IgG antibody syndrome involving both the peripheral and central nervous systems.

Ogawara K, Kuwabara S, Yuki N. Ogawara K, et al. Among authors: yuki n. Muscle Nerve. 2002 Dec;26(6):845-9. doi: 10.1002/mus.10246. Muscle Nerve. 2002. PMID: 12451613

4

Anti-GM1b IgG antibody is associated with acute motor axonal neuropathy and Campylobacter jejuni infection.

Ogawara K, Kuwabara S, Koga M, Mori M, Yuki N, Hattori T. Ogawara K, et al. Among authors: yuki n. J Neurol Sci. 2003 Jun 15;210(1-2):41-5. doi: 10.1016/s0022-510x(03)00013-3. J Neurol Sci. 2003. PMID: 12736086

5

Anti-GQ1b antibody does not affect neuromuscular transmission in human limb muscle.

Kuwabara S, Misawa S, Takahashi H, Sawai S, Kanai K, Nakata M, Mori M, Hattori T, Yuki N. Kuwabara S, et al. Among authors: yuki n. J Neuroimmunol. 2007 Sep;189(1-2):158-62. doi: 10.1016/j.jneuroim.2007.07.001. Epub 2007 Jul 27. J Neuroimmunol. 2007. PMID: 17673301

6

Fisher syndrome: clinical features, immunopathogenesis and management.

Mori M, Kuwabara S, Yuki N. Mori M, et al. Among authors: yuki n. Expert Rev Neurother. 2012 Jan;12(1):39-51. doi: 10.1586/ern.11.182. Expert Rev Neurother. 2012. PMID: 22149656 Review.

7

GQ1b-seronegative Fisher syndrome: clinical features and new serological markers.

Koga M, Gilbert M, Takahashi M, Li J, Hirata K, Kanda T, Yuki N. Koga M, et al. Among authors: yuki n. J Neurol. 2012 Jul;259(7):1366-74. doi: 10.1007/s00415-011-6360-y. Epub 2012 Jan 5. J Neurol. 2012. PMID: 22218648

8

IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome.

Kuwabara S, Yuki N, Koga M, Hattori T, Matsuura D, Miyake M, Noda M. Kuwabara S, et al. Among authors: yuki n. Ann Neurol. 1998 Aug;44(2):202-8. doi: 10.1002/ana.410440210. Ann Neurol. 1998. PMID: 9708542 Clinical Trial.

9

Two patterns of clinical recovery in Guillain-Barré syndrome with IgG anti-GM1 antibody.

Kuwabara S, Asahina M, Koga M, Mori M, Yuki N, Hattori T. Kuwabara S, et al. Among authors: yuki n. Neurology. 1998 Dec;51(6):1656-60. doi: 10.1212/wnl.51.6.1656. Neurology. 1998. PMID: 9855518 Clinical Trial.

10

Antiganglioside antibody in patients with Guillain-Barré syndrome who show bulbar palsy as an initial symptom.

Koga M, Yuki N, Hirata K. Koga M, et al. Among authors: yuki n. J Neurol Neurosurg Psychiatry. 1999 Apr;66(4):513-6. doi: 10.1136/jnnp.66.4.513. J Neurol Neurosurg Psychiatry. 1999. PMID: 10201426 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

592 results

Search Page

Filters